Simplex Trading, LLC Idera Pharmaceuticals, Inc. Transaction History

Simplex Trading, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$0.23 - $0.43 $523 - $977	2,274 New	2,274 $0
Q2 2021 Aug 12, 2021	SELL	$1.01 - $1.58 $203,349 - $318,110	-201,336 Reduced 95.35%	9,822 $11,000
Q1 2021 Apr 26, 2021	BUY	$1.23 - $5.98 $256,196 - $1.25 Million	208,290 Added 7262.55%	211,158 $274,000
Q4 2020 Feb 02, 2021	BUY	$2.09 - $5.18 $5,908 - $14,643	2,827 Added 6895.12%	2,868 $10,000
Q3 2020 Oct 14, 2020	SELL	$1.71 - $2.68 $1,727 - $2,706	-1,010 Reduced 96.1%	41 $0
Q2 2020 Jul 13, 2020	BUY	$1.23 - $2.12 $39 - $67	32 Added 3.14%	1,051 $1,000
Q1 2020 Apr 29, 2020	BUY	$1.06 - $2.15 $1,080 - $2,190	1,019 New	1,019 $1,000
Q3 2019 Oct 15, 2019	SELL	$2.12 - $3.31 $8,908 - $13,908	-4,202 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$2.37 - $3.97 $1,045 - $1,750	-441 Reduced 9.5%	4,202 $11,000
Q1 2019 Apr 18, 2019	BUY	$2.33 - $3.79 $10,818 - $17,596	4,643 New	4,643 $0

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.